Ventana Biotech Financials
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana |
Understanding current and past Ventana Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ventana Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Ventana Biotech's assets may result in an increase in income on the income statement.
Please note, the presentation of Ventana Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ventana Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ventana Biotech's management manipulating its earnings.
Ventana Biotech Stock Summary
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. Ventana Biotech is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1 Bachstrasse, Butschwil, |
| Sector | Financial Services |
| Industry | Shell Companies |
| Benchmark | Dow Jones Industrial |
| Phone | 41 44 732 60 59 |
| Currency | USD - US Dollar |
Ventana Biotech Key Financial Ratios
Ventana Biotech's financial ratios allow both analysts and investors to convert raw data from Ventana Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Ventana Biotech over time and compare it to other companies across industries.Ventana Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ventana Biotech's current stock value. Our valuation model uses many indicators to compare Ventana Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ventana Biotech competition to find correlations between indicators driving Ventana Biotech's intrinsic value. More Info.Ventana Biotech is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 333.33 of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ventana Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ventana Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ventana Biotech Systematic Risk
Ventana Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ventana Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Ventana Biotech correlated with the market. If Beta is less than 0 Ventana Biotech generally moves in the opposite direction as compared to the market. If Ventana Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ventana Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ventana Biotech is generally in the same direction as the market. If Beta > 1 Ventana Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Ventana Biotech November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ventana Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ventana Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ventana Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Ventana Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ventana Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 62.17 | |||
| Information Ratio | 0.1096 | |||
| Maximum Drawdown | 990.0 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 13.04 |
Complementary Tools for Ventana Pink Sheet analysis
When running Ventana Biotech's price analysis, check to measure Ventana Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventana Biotech is operating at the current time. Most of Ventana Biotech's value examination focuses on studying past and present price action to predict the probability of Ventana Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventana Biotech's price. Additionally, you may evaluate how the addition of Ventana Biotech to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |